Pfizer to create separate, internal, global Innovative and Value businesses
- Details
- Category: Pfizer

Bristol-Myers Squibb and Samsung BioLogics announce biopharmaceutical manufacturing relationship
- Details
- Category: Bristol-Myers Squibb

Pfizer statement on PhRMA-EFPIA principles for responsible clinical trial data sharing
- Details
- Category: Pfizer

Bristol-Myers Squibb reports second quarter 2013 financial results
- Details
- Category: Bristol-Myers Squibb

AstraZeneca and Bristol-Myers Squibb resubmit dapagliflozin New Drug Application
- Details
- Category: AstraZeneca

Novartis delivered growth across all divisions in second quarter
- Details
- Category: Novartis

Benefits of Pradaxa® maintained in difficult to treat patients with atrial fibrillation and symptomatic heart failure
- Details
- Category: Boehringer Ingelheim

More Pharma News ...
- GSK announces US submission for dabrafenib/trametinib combination in metastatic melanoma
- Roche halts investigation of aleglitazar
- AstraZeneca collaborates with Cambridge medical research institutions to advance cancer research
- Novartis and Biological E agree to deliver affordable vaccines for typhoid and paratyphoid A fevers to developing world
- GSK and Save the Children launch $1 million award to discover new healthcare innovations for reducing child deaths
- Results of new meta-analysis regarding CV events in linagliptin Phase 3 trials
- AstraZeneca selects location for new global R&D centre and corporate headquarters